CBLL (CBLL) Stock Price & Analysis
CBLL (CBLL) fell 1.66% to USD 24.31 as of September 9, 2026 at 11:42 UTC, according to Nexqual real-time market data.
CBLL last closed at USD 24.31; the session ranged USD 23.84–24.65 on volume of 286,354 shares. Market capitalization is —, with a 52-week range of USD 10.85–25.33 (NMS). Source: Nexqual, September 9, 2026 at 11:42 UTC.
Key Statistics (as of September 9, 2026 at 11:42 UTC)
| Price | USD 24.31 |
|---|---|
| Change | ▼ 1.66% (down) |
| Previous Close | USD 24.31 |
| Open | USD 24.31 |
| Day Range | USD 23.84 – 24.65 |
| 52-Week Range | USD 10.85 – 25.33 |
| Volume | 286,354 shares |
| Market Cap | — |
| Exchange | NMS |
Technical Analysis (CBLL)
Nexqual's technical model rates CBLL "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 9, 2026 at 11:42 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 68.33 (neutral) |
| vs SMA50 | Above (USD 20.76) |
| MACD | 1.17 (positive) |
From CBLL's Latest SEC 10-K Filing (filed 2026-02-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBNX | Beta Bionics, Inc. | USD 19.33 | ▼ 2.96% |
| UPB | Upstream Bio, Inc. | USD 6.19 | ▲ 1.81% |
| KMTS | Kestra Medical Technologies, Lt | USD 25.64 | ▲ 1.97% |
| BCAX | Bicara Therapeutics Inc. | USD 23.71 | ▲ 1.59% |
| NPCE | Neuropace, Inc. | USD 14.76 | ▲ 0.07% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 9, 2026 at 11:42 UTC. This page is informational and not investment advice.